Filing Details
- Accession Number:
- 0001645627-17-000067
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-23 12:55:26
- Reporting Period:
- 2017-05-19
- Filing Date:
- 2017-05-23
- Accepted Time:
- 2017-05-23 12:55:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,877,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,878,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,879,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 300 | $0.05 | 20,880,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,881,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,882,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,883,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,884,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,885,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,886,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,887,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,888,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,889,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,890,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,891,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,892,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,893,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,894,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,895,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,896,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,897,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,898,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,899,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,900,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 110 | $0.05 | 20,900,359 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 890 | $0.05 | 20,901,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,902,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,903,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,904,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,905,249 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
